Literature DB >> 27696226

FAT4 hypermethylation and grade dependent downregulation in gastric adenocarcinoma.

Maryam Pilehchian Langroudi1,2, Novin Nikbakhsh3, Ali Akbar Samadani2, Sadegh Fattahi2, Hassan Taheri4, Shahryar Shafaei5, Galia Amirbozorgi6, Reza Pilehchian Langroudi7, Haleh Akhavan-Niaki8,9.   

Abstract

Gastric cancer is one of the major causes of death due to cancer in the world. It is a multi-factorial disease with epigenetic factors being also involved in its development. FAT4 is a tumor suppressor gene exerting an important role in cell adhesion. This study aimed at analyzing FAT4 expression and promoter methylation in gastric cancer. FAT4 expression was studied in 30 tumoral tissues and their non-tumoral counterparts using Taqman real time PCR method. Promoter methylation was assessed using bisulfite conversion method followed by sequencing. Tumor tissues showed reduced FAT4 expression (P = 0.04). FAT4 downregulation was associated with tumor grade, with higher repression at advanced grades. Significant increase of promoter methylation was observed in tumoral tissues. Reduced expression of FAT4 and increased methylation of its promoter may be one of the effective processes in turning a healthy stomach tissue into a tumor tissue.

Entities:  

Keywords:  FAT4; Gastric cancer; Gene expression; Promoter methylation

Year:  2016        PMID: 27696226      PMCID: PMC5362569          DOI: 10.1007/s12079-016-0355-5

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  35 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

Review 3.  Epigenetic therapy of cancer: past, present and future.

Authors:  Christine B Yoo; Peter A Jones
Journal:  Nat Rev Drug Discov       Date:  2006-01       Impact factor: 84.694

Review 4.  Hypermethylation of tumor suppressor genes in cancer.

Authors:  J G Herman
Journal:  Semin Cancer Biol       Date:  1999-10       Impact factor: 15.707

5.  Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.

Authors:  Sergey I Nikolaev; Donata Rimoldi; Christian Iseli; Armand Valsesia; Daniel Robyr; Corinne Gehrig; Keith Harshman; Michel Guipponi; Olesya Bukach; Vincent Zoete; Olivier Michielin; Katja Muehlethaler; Daniel Speiser; Jacques S Beckmann; Ioannis Xenarios; Thanos D Halazonetis; C Victor Jongeneel; Brian J Stevenson; Stylianos E Antonarakis
Journal:  Nat Genet       Date:  2011-12-25       Impact factor: 38.330

Review 6.  Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.

Authors:  Oliver Galm; Manel Esteller
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

Review 7.  DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy.

Authors:  Jesper Worm; Per Guldberg
Journal:  J Oral Pathol Med       Date:  2002-09       Impact factor: 4.253

Review 8.  Gastric cancer in Iran: epidemiology and risk factors.

Authors:  Reza Malekzadeh; Mohammad H Derakhshan; Zinab Malekzadeh
Journal:  Arch Iran Med       Date:  2009-11       Impact factor: 1.354

Review 9.  Function and cancer genomics of FAT family genes (review).

Authors:  Masaru Katoh
Journal:  Int J Oncol       Date:  2012-10-17       Impact factor: 5.650

10.  Genomic profile analysis of diffuse-type gastric cancers.

Authors:  Yeon-Su Lee; Yun Sung Cho; Geon Kook Lee; Sunghoon Lee; Young-Woo Kim; Sungwoong Jho; Hak-Min Kim; Seung-Hyun Hong; Jung-Ah Hwang; Sook-young Kim; Dongwan Hong; Il Ju Choi; Byung Chul Kim; Byoung-Chul Kim; Chul Hong Kim; Hansol Choi; Youngju Kim; Kyung Wook Kim; Gu Kong; Hyung Lae Kim; Jong Bhak; Seung Hoon Lee; Jin Soo Lee
Journal:  Genome Biol       Date:  2014-04-01       Impact factor: 13.583

View more
  6 in total

Review 1.  Big roles for Fat cadherins.

Authors:  Seth Blair; Helen McNeill
Journal:  Curr Opin Cell Biol       Date:  2017-12-16       Impact factor: 8.382

2.  FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.

Authors:  Shika Hanif Malgundkar; Ikram Burney; Mansour Al Moundhri; Moza Al Kalbani; Ritu Lakhtakia; Aikou Okamoto; Yahya Tamimi
Journal:  BMC Cancer       Date:  2020-05-04       Impact factor: 4.430

3.  An integrated analysis of DNA promoter methylation, microRNA regulation, and gene expression in gastric adenocarcinoma.

Authors:  Hongyun Huang; Lang Xie; Xiaoxuan Feng; Zheng Zheng; Juntao Ouyang; Yan Li; Jinlong Yu
Journal:  Ann Transl Med       Date:  2021-09

Review 4.  Emerging Mechanisms of Growth and Patterning Regulation by Dachsous and Fat Protocadherins.

Authors:  Artem Gridnev; Jyoti R Misra
Journal:  Front Cell Dev Biol       Date:  2022-03-16

5.  A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors.

Authors:  Weili Mao; Jiajing Zhou; Jie Hu; Kui Zhao; Zhenling Fu; Jun Wang; Kaili Mao
Journal:  Front Public Health       Date:  2022-08-16

6.  Association of FLG mutation with tumor mutation load and clinical outcomes in patients with gastric cancer.

Authors:  Fu Yicheng; Liu Xin; Yu Tian; Liu Huilin
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.